NCT01974466

Brief Summary

To compare different goals of fluid resuscitation in early stage of acute pancreatitis

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 1, 2013

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

November 19, 2013

Status Verified

November 1, 2013

Enrollment Period

3.1 years

First QC Date

October 26, 2013

Last Update Submit

November 18, 2013

Conditions

Keywords

pancreatitisresuscitation goal

Outcome Measures

Primary Outcomes (1)

  • Mortality

    28day

Secondary Outcomes (1)

  • intra-abdominal Hypertension

    7 days

Other Outcomes (1)

  • respiratory failure

    14days

Study Arms (2)

Goal A

ACTIVE COMPARATOR

controled fluid therapy: 5\~10ml/kg/hr fulfillment of two or more of four criteria: 1. heart rate \<120 beats/min, 2. mean arterial blood pressure 65-85 mm Hg, 3. urine output ≥1 ml/kg /h 4. Hematocrit ≤35%.

Other: Goal A

Goal B

OTHER

controled fluid therapy: 5\~10ml/kg/hr fulfillment of all of the following criteria: 1 central venous pressure8-12 mmHg , 2.mean arterial pressure 65-85 mm Hg, 3. urine output ≥0.5 ml/kg/h 4. ScvO2 ≤70%

Other: Goal B

Interventions

Goal AOTHER

controled fluid therapy:10\~5ml/kg/h,crystalloid vs colloid 2:1 resuscitation target: fulfillment of two or more of four criteria:1. HR \<120 beats/min, 2.MAP 65-85 mm Hg, 3. urine output ≥1 ml/kg /h 4. HCT ≤35%.

Also known as: Ruijin pancreatitis goal
Goal A
Goal BOTHER

controled fluid therapy:10\~5ml/kg/h,crystalloid vs colloid 2:1 resuscitation target: fulfillment of all of the following criteria: 1 CVP 8-12 mmHg , 2.MAP 65-85 mm Hg, 3. urine output ≥0.5 ml/kg/h 4. ScvO2 ≤70%

Also known as: Sepsis goal
Goal B

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Diagnosis of pancreatitis: Typical pain increase in serum lipase or amylase 2. Onset of abdominal pain within \<=72h before admission 3. moderate severe or severe acute pancreatitis according to Atlanta criteria revisited in 2012 4. Evidence of \>= 1 predictor of fluid resuscitation: Haematocrit \>44% (male) or \>40% (female), respectively Lactate\>4mmol/L; heart rate\>120bpm; urine \<0.5ml/kg/h for 6 hour; Mean arterial pressure\>85 or \<60 mmHg

You may not qualify if:

  • \. Pregnancy 2. New York Heart Association classification \>II 3. With pacemaker implantation 4. chronic obstructive pulmonary disease 5. chronic kidney disease 6. Pre-existing disease with life expectancy \< 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruijin

Shanghai, Shanghai Municipality, 20000, China

RECRUITING

Related Publications (1)

  • Mao EQ, Tang YQ, Fei J, Qin S, Wu J, Li L, Min D, Zhang SD. Fluid therapy for severe acute pancreatitis in acute response stage. Chin Med J (Engl). 2009 Jan 20;122(2):169-73.

    PMID: 19187641BACKGROUND

MeSH Terms

Conditions

Pancreatitis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System Diseases

Study Officials

  • Qiang En Mao, PhD

    Emergency intensive care unit of Ruijin Hospital

    STUDY DIRECTOR
  • Ming zhong, MD

    doctor

    STUDY CHAIR

Central Study Contacts

Zhen er Chen, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 26, 2013

First Posted

November 1, 2013

Study Start

August 1, 2013

Primary Completion

September 1, 2016

Study Completion

August 1, 2017

Last Updated

November 19, 2013

Record last verified: 2013-11

Locations